Literature DB >> 25130889

Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services.

Alistair W Vickery1, Damon Bell2, Jacquie Garton-Smith3, Andrew B Kirke4, Jing Pang5, Gerald F Watts5.   

Abstract

Familial hypercholesterolaemia (FH) is the most common monogenic lipid disorder associated with premature coronary heart disease (CHD). However, the majority of people with FH are undiagnosed or undertreated. Early cholesterol lowering therapy reduces cardiovascular disease mortality in FH. Low awareness and knowledge of FH in specialty and general practice highlights the need for strategies to improve the detection and management of FH. We present an algorithm describing a multidisciplinary approach to FH detection and management. We highlight the role of primary care, and where GPs can work with preventive cardiologists to improve care of FH. Novel strategies to detect index cases with FH are presented including the community laboratory, highlighting patients at high risk of FH, and targeted FH detection through searching the general practice database. General practitioners request over 90% of LDL cholesterol measurements in the community. Once an individual with FH is detected only a small proportion of patients require specialty management with the majority of patients suitably managed in primary care. However, it is crucial to screen family members, as 50% of first-degree family members are expected to have FH due to the autosomal dominant inheritance.
Copyright © 2014 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular diseases; Familial hypercholesterolaemia; Genetic predisposition to disease; Mass screening; Primary health care

Mesh:

Substances:

Year:  2014        PMID: 25130889     DOI: 10.1016/j.hlc.2014.07.062

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  9 in total

1.  Knowledge and Awareness of Familial Hypercholesterolaemia among Registered Medical Practitioners in Tamil Nadu: Are They Suboptimal?

Authors:  Nandhini Rangarajan; Shanthi Balasubramanian; Jing Pang; Gerald F Watts
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  Knowns and unknowns in the care of pediatric familial hypercholesterolemia.

Authors:  Andrew C Martin; Samuel S Gidding; Albert Wiegman; Gerald F Watts
Journal:  J Lipid Res       Date:  2017-07-12       Impact factor: 5.922

3.  PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Authors:  Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska
Journal:  Arch Med Sci       Date:  2021-11-08       Impact factor: 3.318

4.  Improving detection and management of familial hypercholesterolaemia in Australian general practice.

Authors:  Tom Brett; Dick C Chan; Jan Radford; Clare Heal; Gerard Gill; Charlotte Hespe; Cristian Vargas-Garcia; Carmen Condon; Barbara Sheil; Ian W Li; David R Sullivan; Alistair W Vickery; Jing Pang; Diane E Arnold-Reed; Gerald F Watts
Journal:  Heart       Date:  2021-05-20       Impact factor: 5.994

Review 5.  Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.

Authors:  Albert Wiegman; Samuel S Gidding; Gerald F Watts; M John Chapman; Henry N Ginsberg; Marina Cuchel; Leiv Ose; Maurizio Averna; Catherine Boileau; Jan Borén; Eric Bruckert; Alberico L Catapano; Joep C Defesche; Olivier S Descamps; Robert A Hegele; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Jan Albert Kuivenhoven; Luis Masana; Børge G Nordestgaard; Päivi Pajukanta; Klaus G Parhofer; Frederick J Raal; Kausik K Ray; Raul D Santos; Anton F H Stalenhoef; Elisabeth Steinhagen-Thiessen; Erik S Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen; Olov Wiklund
Journal:  Eur Heart J       Date:  2015-05-25       Impact factor: 29.983

6.  Detection and management of familial hypercholesterolaemia in primary care in Australia: protocol for a pragmatic cluster intervention study with pre-post intervention comparisons.

Authors:  Diane E Arnold-Reed; Tom Brett; Lakkhina Troeung; Alistair Vickery; Jacquie Garton-Smith; Damon Bell; Jing Pang; Tegan Grace; Caroline Bulsara; Ian Li; Max Bulsara; Gerald F Watts
Journal:  BMJ Open       Date:  2017-10-22       Impact factor: 2.692

Review 7.  Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management.

Authors:  Maria Mytilinaiou; Ioannis Kyrou; Mike Khan; Dimitris K Grammatopoulos; Harpal S Randeva
Journal:  Front Pharmacol       Date:  2018-07-12       Impact factor: 5.810

8.  The Gen-Equip Project: evaluation and impact of genetics e-learning resources for primary care in six European languages.

Authors:  Leigh Jackson; Anita O'Connor; Milena Paneque; Vaclava Curtisova; Peter W Lunt; Radka Kremlíková Pourova; Milan Macek; Vigdis Stefansdottir; Daniela Turchetti; Mariana Campos; Lidewij Henneman; Lea Godino; Heather Skirton; Martina C Cornel
Journal:  Genet Med       Date:  2018-07-27       Impact factor: 8.822

9.  Improving detection of familial hypercholesterolaemia in primary care using electronic audit and nurse-led clinics.

Authors:  Peter Green; Dermot Neely; Steve E Humphries
Journal:  J Eval Clin Pract       Date:  2015-11-26       Impact factor: 2.431

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.